How did Evogene's revenue and expenses shift in Q4 2024?
5/8/2025 06:30pm
Evogene's revenue for Q4 2024 was $1.61 million, while the specific expenses for the quarter are not available. The lack of detailed expense information makes it challenging to provide a comprehensive analysis of the company's financial performance for the period. However, the reported revenue indicates that Evogene generated a positive income stream during this quarter, which is a favorable sign for the company's financial health and operational effectiveness.
|code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code|
|---|---|---|---|---|---|---|
|EVGN|EVGN.O|Evogene|2024 Q1|4190000||186|
|EVGN|EVGN.O|Evogene|2024 Q2|914000||186|
|EVGN|EVGN.O|Evogene|2024 Q3|1796000||186|
|EVGN|EVGN.O|Evogene|2024 Q4|1611000||186|